Zobrazeno 1 - 10 of 83 pro vyhledávání: '"Patty M. Jansen"'
1
Akademický článek
Mycosis Fungoides and Associated Malignancies in a Dutch Nationwide Retrospective Cohort Study
Autor: Rosanne Ottevanger, Esther Vermaas, Rein Willemze, Anne-Roos Schrader, Patty M. Jansen, Jelle J. Goeman, Hein Putter, Maarten H. Vermeer, Koen D. Quint
Publikováno v: Acta Dermato-Venereologica, Vol 104 (2024)
The prognosis of patients with mycosis fungoides is variable. As the current literature is scarce and shows mixed results this study investigates the incidence of other primary malignancies in mycosis fungoides patients. A retrospective, nationwide,
Externí odkaz: https://doaj.org/article/18e48b1ef4424bd58f911273db0bb379
Zobrazit plný text záznamu
2
Akademický článek
Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant
Autor: Melanie de Gier, Ingrid Pico-Knijnenburg, Monique M. van Ostaijen-ten Dam, Dagmar Berghuis, Frans J. Smiers, Adriaan A. van Beek, Hetty Jolink, Patty M. Jansen, Arjan C. Lankester, Mirjam van der Burg
Publikováno v: Frontiers in Immunology, Vol 15 (2024)
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for various hematological, immunological and metabolic diseases, replacing the patient’s hematopoietic system with donor-derived healthy hematopoietic stem cells. HSC
Externí odkaz: https://doaj.org/article/43cc956a59494f48bfa1c4c189550255
Zobrazit plný text záznamu
3
Akademický článek
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands
Autor: Frederik O. Meeuwes, Mirian Brink, Wouter Plattel, Marjolein W.M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F.J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Karen J. Neelis, Anne P.G. Crijns, Laurien A. Daniëls, Tjeerd J.F. Snijders, Joost S.P. Vermaat, Gerwin A. Huls, Marcel Nijland
Publikováno v: Haematologica, Vol 109, Iss 4 (2023)
Peripheral T-cell lymphomas (PTCL) comprise a heterogeneous group of mature T-cell neoplasms with an unfavorable prognosis; presentation with stage I(E) disease is uncommon. In clinical practice, an abbreviated chemotherapy treatment regimen combined
Externí odkaz: https://doaj.org/article/d532ebf989584755b6c1807cd5d0ae28
Zobrazit plný text záznamu
4
Akademický článek
Concomitant Choroidal Melanoma and Non-Hodgkin Lymphoma in Two Adult Patients: Case Report
Autor: Marcel Vlaskamp, Didi de Wolff-Rouendaal, Patty M. Jansen, Gre P.M. Luyten
Publikováno v: Case Reports in Ophthalmology, Vol 3, Iss 2, Pp 209-213 (2012)
Objective: To report two cases of concomitant choroidal melanoma and intraocular non-Hodgkin lymphoma in two patients. Design: Case report. Participants: Two patients with yellow creamy infiltrates in fundo. Intervention: Both patients had a complete
Externí odkaz: https://doaj.org/article/cd68f256e3ab4424af1d75fa8f1a7e7e
Zobrazit plný text záznamu
8
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype
Autor: Arjan Diepstra, Ronald van Eijk, Henriette Levenga, Valeska Terpstra, Joost S.P. Vermaat, Lizan Hardi, Richard Raghoo, Marie José Kersten, Tom van Wezel, Arjen H.G. Cleven, Dina Ruano, Liane te Boome, Inge H. Briaire-de Bruijn, Wietske C. E. den Hartog, Fleur A de Groot, Steven T. Pals, Patty M. Jansen, Isabelle Focke-Snieders, Hendrik Veelken, Pancras C.W. Hogendoorn, Marcel Nijland, Anke van den Berg, Pieternella J. Lugtenburg, Judith V.M.G. Bovée, Alina Nicolae, Karin Kleiverda, Ruben A.L. de Groen, Eduardus F. M. Posthuma, Stefan Böhringer, Lara H Böhmer
Publikováno v: Blood Adv
Blood Advances, 5(19), 3760-3775. ELSEVIER
Blood Advances, 5(19):2021005215, 3760-3775. AMER SOC HEMATOLOGY
Blood advances, 5(19), 3760-3775. American Society of Hematology
Primary bone diffuse large B-cell lymphoma (PB-DLBCL) is a rare extranodal lymphoma subtype. This retrospective study elucidates the currently unknown genetic background of a large clinically well-annotated cohort of DLBCLwith osseous localizations (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893bdaca8a68507a17b4f41ffca29462
https://doi.org/10.1182/bloodadvances.2021005215
Zobrazit plný text záznamu
9
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis
Autor: Frederik O. Meeuwes, Mirian Brink, Marjolein W.M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G.N.J. Mutsaers, Lara Böhmer, Sherida Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Arjan Diepstra, Tjeerd J.F. Snijders, Wouter J. Plattel, Gerwin A. Huls, Joost S.P. Vermaat, Marcel Nijland
Publikováno v: European Journal of Cancer, 176, 100-109. Elsevier Limited
European Journal of Cancer, 176, 100-109. ELSEVIER SCI LTD
European Journal of Cancer, 176, 100-109. Elsevier Ltd.
European Journal of Cancer, 176, 100-109. Pergamon
Meeuwes, F O, Brink, M, van der Poel, M W M, Kersten, M J, Wondergem, M, Mutsaers, P G N J, Böhmer, L, Woei-A-Jin, S, Visser, O, Oostvogels, R, Jansen, P M, Diepstra, A, Snijders, T J F, Plattel, W J, Huls, G A, Vermaat, J S P & Nijland, M 2022, ' Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis ', European Journal of Cancer, vol. 176, pp. 100-109 . https://doi.org/10.1016/j.ejca.2022.09.008
Background: Patients with angioimmunoblastic T-cell lymphoma (AITL) are treated with cyclophosphamide, doxorubicin, vincristine and prednisone with or without etoposide (CHO(E)P). In the majority of cases, Epstein-Barr virus (EBV)-positive B-cells ar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee6600c3d6deee45e15fb80ac918567
https://pure.amc.nl/en/publications/impact-of-rituximab-on-treatment-outcomes-of-patients-with-angioimmunoblastic-tcell-lymphoma-a-populationbased-analysis(bf8c7332-cf3c-4980-bb7f-8c944781d35a).html
Zobrazit plný text záznamu
10
Genetic stability of driver alterations in primary cutaneous diffuse large B-Cell lymphoma, leg type and their relapses: a rationale for the use of molecular-based methods for more effective disease monitoring
Autor: Anne M. R. Schrader, Ruben A. L. de Groen, Rein Willemze, Patty M. Jansen, Koen D. Quint, Arjen H. G. Cleven, Tom van Wezel, Ronald van Eijk, Dina Ruano, J. H. (Hendrik) Veelken, Cornelis P. Tensen, Karen J. Neelis, Laurien A. Daniels, Esther Hauben, F. J. S. H. (Sherida) Woei-A-Jin, A. M. (Annemie) Busschots, Maarten H. Vermeer, Joost S. P. Vermaat
Publikováno v: Cancers, 14(20). MDPI
Cancers; Volume 14; Issue 20; Pages: 5152
Cancers, 14(20):5152. MDPI AG
Cancers, 14(20):5152. Multidisciplinary Digital Publishing Institute (MDPI)
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is a rare, aggressive cutaneous lymphoma with a 5-year disease-specific survival of only ~55%. Despite high response rates to initial immune-polychemotherapy, most patients experi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c212f828300d1f5e66c73fe08096193e
http://hdl.handle.net/1887/3563422
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje